|Public Meeting on Patient-Focused Drug Development for Vitiligo|
Zeitzone Europe/Berlin .
On March 8, 2021, FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Vitiligo. FDA is interested in hearing patients’ perspectives on the impact of vitiligo on daily life and patient views on treatment approaches.
This website will be updated as meeting materials are developed.
March 8, 2021
10:00 a.m. - 2:30 p.m. EST